drugset / Trial / NCT04221321

Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers

NCT04221321

Phase 1 Completed 32 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the influence of tegoprazan or RAPA114 on the Pharmacokinetic characteristics of atorvastatin following co-administration of tegoprazan or RAPA114 in healthy adult volunteers.

Timeline

Start
2020-01-07
Primary completion
2020-03-12
Completion
2020-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg Oral
Comparator RAPA114 Unknown Oral
Subject Tegoprazan Other / unclassified 50 mg Oral

Indications

No indication recorded.